Vital Statistics
| Class |
Ticker |
CUSIP |
Fund Number |
| Investor |
PHPIX |
743185423 |
047 |
| Service |
PHPSX |
743185415 |
077 |
Inception Date for all share classes is
6/28/2000
NAV
as of 2/3/2012
|
Class
|
NAV
|
% Change
|
$ Change
|
|
Investor
|
$10.41
|
0.48%
|
$0.05
|
|
Service
|
$9.86
|
0.41%
|
$0.04
|
Historical NAVs
Investor Class
Service Class
ObjectiveThe Pharmaceuticals UltraSector ProFund seeks daily investment results, before fees and expenses, that are 1.5x the return of the Dow Jones U.S. PharmaceuticalsSM Index (the "Index") for a single day.
Dow Jones U.S. Pharmaceuticals Index
The Index (Bloomberg symbol: DJUSPR) measures the performance of the pharmaceuticals sector of the U.S. equity market. Component companies include, among others, the makers of prescription and over-the-counter drugs, such as birth control pills, vaccines, aspirin and cold remedies. It is not possible to invest directly in an index
Index (as of 12/31/2011)
Top 10 Index Companies
|
Name
|
Weight
|
|
Johnson & Johnson
|
24.01%
|
|
Pfizer Inc.
|
22.24%
|
|
Merck & Co. Inc.
|
15.45%
|
|
Abbott Laboratories
|
11.68%
|
|
Bristol-Myers Squibb Co.
|
8.07%
|
|
Eli Lilly & Co.
|
5.43%
|
|
Allergan Inc.
|
3.61%
|
|
Mylan Inc.
|
1.24%
|
|
Pharmasset Inc.
|
1.18%
|
|
Perrigo Co.
|
1.12%
|
Total Index Companies
25
Average Index Market Capitalization
30.02 billion
Fund Statistics
|
Limits On Exchanges
|
None
|
|
Minimum Investment
|
Individual Investor
|
$15,000
|
Financial Professionals
|
$5,000
|
All data, unless otherwise noted, is as of 12/31/2011 and for Investor Class Shares only and is subject to change.
Narrowly focused investments typically exhibit higher volatility.
|